Pricing Log in Create free account
Saturday 17 October 2026 Export GILD’s income statement to Excel — free account

Gilead Sciences, Inc.

GILD Healthcare Drug Manufacturers General

Gilead Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $29.4 billion, up 2.40% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS fell 638.2%, free cash flow grew 376.8% and total debt rose 5.21%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for ten consecutive years.

156.19 1.18 −0.75%
Market cap
$195.1B
P/E
0.0×
Fwd P/E
−46.2×
Dividend yield
2.08%
F-score
8/9
Altman Z
4.03
Beneish M
−2.45
Dividend safety
77/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Gilead Sciences, Inc. (GILD) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, Gilead Sciences, Inc. (GILD) trades at a P/S ratio of 6.4×. Over the past ten years it has ranged from 2.6× (June 2022) to 6.6× (June 2015); the current reading is higher than 99% of that period. That is above the Drug Manufacturers General industry median of 3.4× and above the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 5.2× 29.46%
FY2024 4.0× 4.56%
FY2023 3.8× (2.47%)
FY2022 3.9× 17.61%
FY2021 3.3× 12.60%
FY2020 3.0× (19.31%)
FY2019 3.7× 0.19%
FY2018 3.7× (1.09%)
FY2017 3.7× 13.53%
FY2016 3.3× (28.01%)

Quarterly newest first

Period P/S ratio Change
Jun 2026 5.2× (11.42%)
Mar 2026 5.8× 12.25%
Dec 2025 5.2× 9.33%
Sep 2025 4.7× (0.81%)
42 more quarters

Against its own ten years

Low 2.6× High 6.6×
Ten-year median 3.7×
Current reading's percentile 100

P/S ratio against peers

Company P/S ratio
GSK GSK PLC Sponsored ADR compare 2.2×
BMY Bristol Myers Squibb Company compare 2.5×
PFE Pfizer Inc. compare 2.6×
NVO Novo Nordisk A/S compare 3.3×
AZN AstraZeneca PLC compare 4.2×
NVS Novartis AG compare 5.1×
MRK Merck & Co., Inc. compare 5.4×
AMGN Amgen Inc. compare 6.1×
GILD Gilead Sciences, Inc. 6.4×
Drug Manufacturers General industry median 3.4×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on GILD